PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

68 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
Zemva, J.* et al.: Effects of the reactive metabolite methylglyoxal on cellular signalling, insulin action and metabolism – What we know in mammals and what we can learn from yeast. Exp. Clin. Endocrinol. Diabet. 127, 203-214 (2019)
42.
Kopf, S.* & Nawroth, P.P.: Diabetic pulmopathy: A new clinical challenge for diabetology. Exp. Clin. Endocrinol. Diabet. 126, 590-591 (2018)
43.
Neschen, S. et al.: Impact of brain fatty acid signaling on peripheral insulin action in mice. Exp. Clin. Endocrinol. Diabet. 126, 20-29 (2018)
44.
Kasperk, C.* ; Georgescu, C.* & Nawroth, P.P.: Diabetes mellitus and bone metabolism. Exp. Clin. Endocrinol. Diabet. 26, 90-94 (2017)
45.
Kufeldt, J. et al.: Prevalence and distribution of diabetes mellitus in a maximum care hospital: Urgent need for HbA(1c)-screening. Exp. Clin. Endocrinol. Diabet. 126, 123-129 (2017)
46.
Kumar, V.* ; Sulaj, A.* ; Fleming, T.* & Nawroth, P.P.: Purification and Characterization of the Soluble form of the Receptor for Advanced Glycation End-Products (sRAGE): A Novel Fast, Economical and Convenient Method. Exp. Clin. Endocrinol. Diabet. 126, 141-147 (2017)
47.
Auer, M.* et al.: Pilot study on the effects of cross-sex hormone treatment in transsexual persons on metabolism by means of metabolomics profiling. Exp. Clin. Endocrinol. Diabet. 123:P09_16 (2015)
48.
Lehmann, R. et al.: Metabolic profiles during an oral glucose tolerance test in pregnant women with and without gestational diabetes. Exp. Clin. Endocrinol. Diabet. 123, 433-438 (2015)
49.
Schütt, M.* et al.: Gender-specific effects of treatment with lifestyle, metformin or sulfonylurea on glycemic control and body weight: A German multicenter analysis on 9108 patients. Exp. Clin. Endocrinol. Diabet. 65, 622-626 (2015)
50.
Beck, I.* ; Schmidt-Weber, C.B. ; Eyerich, K.* ; Chen, W.* & Traidl-Hoffmann, C.*: Immune modulatory effects of sex hormones and leptin on monocytes and CD4+T cells. Exp. Clin. Endocrinol. Diabet. 122:P058 (2014)
51.
Berti, L. et al.: FGF21 inhibits adiponectin secretion in human adipocytes. Exp. Clin. Endocrinol. Diabet. 122:OP4_11 (2014)
52.
Gancheva, S.* et al.: Acute effects of intranasal insulin on endogenous glucose production and hepatic energy metabolism in humans. Exp. Clin. Endocrinol. Diabet. 122:P163 (2014)
53.
Kaiser, G. ; Gerst, F. ; Stefan, N. ; Ullrich, S. & Häring, H.-U.: The hepatokine fetuin-A associates with insulin resistance and induces inflammation but selectively improves cAMP-dependent insulin secretion of human islets. Exp. Clin. Endocrinol. Diabet. 122:OP4_13 (2014)
54.
Kruse, M.* et al.: A high-fat diet during pregnancy and lactation targets GIP-regulated metabolic pathways in male offspring in mice. Exp. Clin. Endocrinol. Diabet. 122:P012 (2014)
55.
Mühlhaus, J.* et al.: Aspects of 3-iodothyronamine (3T1AM) induced signaling by human and mouse trace amine-associated receptor 5 (TAAR5). Exp. Clin. Endocrinol. Diabet. 122:OP7_38 (2014)
56.
Peter, A. et al.: The I148 M variant in PNPLA3 is associated with altered hepatic lipid composition in humans. Exp. Clin. Endocrinol. Diabet. 122:P059 (2014)
57.
Riester, A.* et al.: Prevalence and clinical correlates of CACNA1D mutations in primary aldosteronism. Exp. Clin. Endocrinol. Diabet. 122:OP5_20 (2014)
58.
Wolf, S.* et al.: CNS impact of the GLP-1-Estrogen conjugate on food-motivated behavior. Exp. Clin. Endocrinol. Diabet. 122:P139 (2014)
59.
Claessen, H.* et al.: Medication costs by glucose tolerance stage in younger and older women and men: Results from the population-based KORA survey in Germany. Exp. Clin. Endocrinol. Diabet. 121, 614-623 (2013)
60.
Nagel, J.M.* et al.: Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: An unexpected finding? Exp. Clin. Endocrinol. Diabet. 120, 224-228 (2012)